Zacks Investment ResearchTue, 23 Jun 2026 14:40:46 GMTAre Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?COLL-1.15%
Seeking AlphaThu, 07 May 2026 17:51:19 GMTCollegium Pharmaceutical, Inc. (COLL) Q1 2026 Earnings Call TranscriptCOLL-1.15%
Zacks Investment ResearchThu, 07 May 2026 14:31:29 GMTCollegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesCOLL-1.15%
Zacks Investment ResearchThu, 07 May 2026 13:56:20 GMTCollegium Pharmaceutical (COLL) Q1 Earnings and Revenues Beat EstimatesCOLL-1.15%
The Motley FoolTue, 31 Mar 2026 01:12:05 GMTCollegium's General Counsel Trims His Stake as the Company Doubles Down on ADHDCOLL-1.15%
